$ESSA Pharma (EPIX.US)$ 10% Shareholder BIOTECH GROWTH N V sold 7.88 million shares of common stock on Nov 1, 2024 at an average price of $1.5253 for a total value of $12.02 million.
This transaction involves other related parties: BB BIOTECH AG.
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.
